Hongming Pan

1.6k total citations
56 papers, 907 citations indexed

About

Hongming Pan is a scholar working on Oncology, Biomedical Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hongming Pan has authored 56 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 13 papers in Biomedical Engineering and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hongming Pan's work include Luminescence Properties of Advanced Materials (9 papers), Solid State Laser Technologies (7 papers) and Optical Coherence Tomography Applications (6 papers). Hongming Pan is often cited by papers focused on Luminescence Properties of Advanced Materials (9 papers), Solid State Laser Technologies (7 papers) and Optical Coherence Tomography Applications (6 papers). Hongming Pan collaborates with scholars based in China, Italy and United States. Hongming Pan's co-authors include Jiang Li, Zewang Hu, Xianfeng Gu, Kejing Ying, Weijun Hu, Zhijun Wang, Wei Guo, Ping Wang, Xing Chen and Yi Li and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Chemistry and Cancer Research.

In The Last Decade

Hongming Pan

51 papers receiving 893 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongming Pan China 19 295 285 255 166 109 56 907
Jian Shen China 15 227 0.8× 572 2.0× 198 0.8× 348 2.1× 11 0.1× 43 1.4k
Yunjian Wang China 25 102 0.3× 952 3.3× 582 2.3× 186 1.1× 39 0.4× 90 1.6k
Weibo Chen China 20 68 0.2× 368 1.3× 216 0.8× 445 2.7× 45 0.4× 66 1.3k
Shaoxin Li China 20 263 0.9× 154 0.5× 85 0.3× 289 1.7× 20 0.2× 56 1.0k
Hua Yu China 19 101 0.3× 134 0.5× 130 0.5× 287 1.7× 12 0.1× 65 1.0k
Tatsuya Niimi Japan 23 95 0.3× 270 0.9× 389 1.5× 569 3.4× 23 0.2× 82 1.4k
Shingo Hirose Japan 16 176 0.6× 158 0.6× 200 0.8× 251 1.5× 10 0.1× 108 882
Sungyun Kim South Korea 18 269 0.9× 229 0.8× 94 0.4× 128 0.8× 16 0.1× 42 825
Huidong Gu United States 19 98 0.3× 319 1.1× 105 0.4× 336 2.0× 21 0.2× 53 1.2k
Noramaliza Mohd Noor Malaysia 18 106 0.4× 238 0.8× 146 0.6× 144 0.9× 107 1.0× 73 908

Countries citing papers authored by Hongming Pan

Since Specialization
Citations

This map shows the geographic impact of Hongming Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongming Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongming Pan more than expected).

Fields of papers citing papers by Hongming Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongming Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongming Pan. The network helps show where Hongming Pan may publish in the future.

Co-authorship network of co-authors of Hongming Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Hongming Pan. A scholar is included among the top collaborators of Hongming Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongming Pan. Hongming Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Xu, Huiting, Jianwei Yang, Haiping Jiang, et al.. (2024). Pharmacokinetics of infigratinib and its active metabolites in Chinese patients with advanced gastric cancer harboring FGFR2 gene amplification. Clinical and Translational Science. 17(12). e70091–e70091. 3 indexed citations
5.
Shen, Jiaying, et al.. (2024). Association of frailty with mortality in cancer survivors: results from NHANES 1999–2018. Scientific Reports. 14(1). 1619–1619. 9 indexed citations
7.
Yang, Zihan, et al.. (2023). Deep-Learning-Based Automated Identification and Visualization of Oral Cancer in Optical Coherence Tomography Images. Biomedicines. 11(3). 802–802. 26 indexed citations
8.
Zhu, Xudong, et al.. (2023). Efficacy and safety of PD‑1 inhibitor plus antiangiogenic treatment in patients with unresectable biliary tract cancer: A multicenter retrospective study. Experimental and Therapeutic Medicine. 26(1). 352–352. 1 indexed citations
9.
Qiu, Miao‐Zhen, Hongming Pan, Ka On Lam, et al.. (2023). An open-label, single-arm, dose escalation and expansion phase 1 study of tebotelimab (MGD013) plus niraparib in patients with locally advanced or metastatic gastric cancer who failed prior treatments.. Journal of Clinical Oncology. 41(4_suppl). 402–402. 5 indexed citations
10.
Pan, Hongming, et al.. (2022). Classification of neck tissues in OCT images by using convolutional neural network. Lasers in Medical Science. 38(1). 21–21.
11.
Liang, X. H., Ju-Jun Xie, Hao Liu, et al.. (2022). STIM1 Deficiency In Intestinal Epithelium Attenuates Colonic Inflammation and Tumorigenesis by Reducing ER Stress of Goblet Cells. Cellular and Molecular Gastroenterology and Hepatology. 14(1). 193–217. 22 indexed citations
12.
Zhang, Xiaoling, Hao Liu, Haidong Wang, et al.. (2022). B3galt5 deficiency attenuates hepatocellular carcinoma by suppressing mTOR/p70s6k-mediated glycolysis. Cellular and Molecular Life Sciences. 80(1). 8–8. 6 indexed citations
13.
Edeline, Julien, Philippe Merle, Weijia Fang, et al.. (2022). Clinical outcomes associated with tislelizumab in patients (pts) with advanced hepatocellular carcinoma (HCC) who have been previously treated with sorafenib (SOR) or lenvatinib (LEN) in RATIONALE-208.. Journal of Clinical Oncology. 40(16_suppl). 4072–4072. 2 indexed citations
14.
Yang, Di, et al.. (2020). Axial Super-Resolution Study for Optical Coherence Tomography Images Via Deep Learning. IEEE Access. 8. 204941–204950. 21 indexed citations
15.
Pan, Hongming, et al.. (2020). More realistic low-resolution OCT image generation approach for training deep neural networks. OSA Continuum. 3(11). 3197–3197. 8 indexed citations
16.
Pan, Hongming, et al.. (2020). Multimodal imaging with integrated auto-fluorescence and optical coherence tomography for identification of neck tissues. Lasers in Medical Science. 36(5). 1023–1029. 1 indexed citations
17.
Liu, Ziyu, Guido Toci, Angela Pirri, et al.. (2019). Fabrication and laser operation of Yb:Lu 2 O 3 transparent ceramics from co‐precipitated nano‐powders. Journal of the American Ceramic Society. 102(12). 7491–7499. 31 indexed citations
18.
Wang, Zhijun, Lingling Chang, Jian Wu, et al.. (2019). A Novel Rhynchophylline Analog, Y396, Inhibits Endothelial Dysfunction Induced by Oxidative Stress in Diabetes Through Epidermal Growth Factor Receptor. Antioxidants and Redox Signaling. 32(11). 743–765. 20 indexed citations
19.
Li, Wei, Huamin Kou, Wenhua Zhang, et al.. (2019). Preparation and characterization of multilayer Gd2O2S:Tb phosphor screen for X‐ray detection application. International Journal of Applied Ceramic Technology. 17(3). 1440–1444. 17 indexed citations
20.
Li, Xiaoying, Qiang Liu, Hongming Pan, et al.. (2019). Transparent Tb3Ga5O12 magneto-optical ceramics sintered from co-precipitated nano-powders calcined at different temperatures. Optical Materials. 90. 26–32. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026